Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

One very influential set of guidelines — viewed more than 50 million times and used by doctors around the world — is the COVID-19 Treatment Guidelines from the National Institutes of Health (NIH).

“Some people think that if they got the vaccine or feel healthy, they don’t need treatment,” said Karyne Jones, President and CEO of NCBA, Inc. and co-convener of CVEEP. “But that’s not always true.

One very influential set of guidelines — viewed more than 50 million times and used by doctors around the world — is the COVID-19 Treatment Guidelines from the National Institutes of Health (NIH).

This is a MedPage Today story. As patients with long COVID-19 scour the internet desperate for relief, physicians are concerned they may stumble upon an unproven treatment plan touted by a group ...

The treatment of choice for a while In 2020, then-President Donald Trump said he had been taking hydroxychloroquine to prevent a COVID-19 infection, despite warnings by the U.S. Food and Drug ...

A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients. eLife, 2024; 13 DOI: 10.7554/eLife.89801 ...

Step 3 After You Test Positive For COVID-19: Ask A Medical Professional About Treatment Options Paxlovid is one of the two oral antivirals available for Covid-19 treatment.

The treatment of lab-created monoclonal antibodies is meant to be used in the early stages of infection, to help patients -- those at high-risk for severe illness -- recover from COVID-19.

In our vibrant and tight-knit community, staying healthy is a shared responsibility that helps strengthen our collective well-being. COVID-19 has tested us in ways we never imagined, but with the ...

Although we may not hear much about it these days, long COVID-19 is still out there. In the beginning, treatment seemed to be a hit-and-miss, but the approach has had a breakthrough.